Hype Vs Hands On: The Truth About End-To-End Manufacturing Automation

As cell and gene therapies evolve from groundbreaking clinical innovations to viable commercial products, the industry faces a critical inflection point: how to scale these therapies without sacrificing quality, cost-efficiency, or speed. The true bottlenecks lie not in scientific discovery, but in the infrastructure that supports manufacturing. This webinar will delve into how end-to-end automation, modular platform design, and real-time analytics are revolutionizing the production of advanced therapies. Gain practical insights into identifying automation-ready steps early in development, integrating in-line analytics—ranging from optical and sensor-based to computational—and designing adaptable systems that can evolve alongside emerging therapy types.